Microbot Medical, Emory University to Consider LIBERTY Robotic System Partnership

Microbot Medical Inc. and Emory University are exploring the possibility of collaborating in autonomous robotics for endovascular procedures.

Under the terms an agreement reached by the two parties, Emory University will consider the feasibility of integrating the LIBERTY Endovascular Robotic Surgical System with an imaging system to create an autonomous robotic system for endovascular procedures. Amir Pourmorteza, Ph.D., assistant professor in the Department of Radiology and Imaging Sciences at Emory University Winship Cancer Institute, and Department of Biomedical Engineering at Georgia Institute of Technology, will lead the evaluation under Project Trita.
 
“Autonomous robotics has the potential to standardize outcomes, improve efficiencies, reduce radiation exposure, and democratize access to top-level healthcare,” Dr. Pourmorteza said. “Project Trita merges CT guidance, artificial intelligence, and medical robotics. I am excited to work with Microbot Medical on this project.”
 
“Our vision for the future of endovascular robotics includes autonomous capabilities, which has the potential to standardize endovascular procedures and improve access to benefit millions of patients globally. We believe LIBERTY can be integrated with imaging, planning and navigation software to ultimately create an autonomous robotic system that can be used in endovascular procedures,” Microbot Medical Chairman, President, and CEO Harel Gadot added. “We’re excited to work with Dr. Pourmorteza who is a leader in this space and we believe he shares a similar vision.”
 
Microbot Medical Inc. is a clinical- stage medical device company that specializes in transformational micro-robotic technologies, with the goals of improving clinical outcomes for patients and increasing accessibility through the natural and artificial lumens within the human body.
 
The Investigational LIBERTY Endovascular Robotic Surgical System aims to improve the way surgical robotics are being used in endovascular procedures by eliminating the need for large, cumbersome, and expensive capital equipment while reducing radiation exposure and physician strain. The company believes the LIBERTY Endovascular Robotic Surgical System’s remote operation can potentially be the first system to democratize endovascular interventional procedures.